Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Genentech’s New NMOSD Drug Offers At-Home Treatment, Lower Cost
List price is below competitors from Alexion, Viela Bio
Aug 16 2020
•
By
Mandy Jackson
Enspryng previously was approved in Canada, Japan and Switzerland • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from New Products
More from Scrip